New York State Common Retirement Fund
TCRR

New York State Common Retirement Fund’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

New York State Common Retirement Fund’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-270
Closed -$1K – 3538
2022
Q2 		$1K Sell
270
-13,493
-98% -$33.3K ﹤0.01% 3456
2022
Q1 		$38K Hold
13,763
– – ﹤0.01% 3222
2021
Q4 		$64K Sell
13,763
-217
-2% -$1.36K ﹤0.01% 3181
2021
Q3 		$119K Sell
13,980
-13,747
-50% -$194K ﹤0.01% 3086
2021
Q2 		$455K Buy
27,727
+4,734
+21% +$95.6K ﹤0.01% 2654
2021
Q1 		$508K Hold
22,993
– – ﹤0.01% 2455
2020
Q4 		$711K Buy
22,993
+8,000
+53% +$202K ﹤0.01% 2178
2020
Q3 		$305K Hold
14,993
– – ﹤0.01% 2460
2020
Q2 		$230K Buy
14,993
+2,193
+17% +$25.3K ﹤0.01% 2579
2020
Q1 		$99K Hold
12,800
– – ﹤0.01% 2771
2019
Q4 		$183K Buy
12,800
+6,400
+100% +$98.9K ﹤0.01% 2776
2019
Q3 		$96K Sell
6,400
-600
-9% -$9.35K ﹤0.01% 3043
2019
Q2 		$100K Buy
+7,000
New +$112K ﹤0.01% 3115

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's TCRR Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q3 2022, closing a stake of 270 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in TCRR in Q2 2019 and held it in 13 quarters. The position peaked at $711K in Q4 2020. 81 funds tracked by Wall St. Rank hold TCRR as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 270 TCR2 Therapeutics Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in TCR2 Therapeutics Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • New York State Common Retirement Fund's TCR2 Therapeutics Inc. Common Stock position peaked at $711K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.